Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.100
-0.010 (-0.90%)
Nov 6, 2025, 4:00 PM EST - Market closed
Heron Therapeutics Employees
Heron Therapeutics had 122 employees as of December 31, 2024. The number of employees decreased by 4 or -3.17% compared to the previous year.
Employees
122
Change (1Y)
-4
Growth (1Y)
-3.17%
Revenue / Employee
$1,271,287
Profits / Employee
-$111,295
Market Cap
201.70M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 122 | -4 | -3.17% |
| Dec 31, 2023 | 126 | -77 | -37.93% |
| Dec 31, 2022 | 203 | -99 | -32.78% |
| Dec 31, 2021 | 302 | 79 | 35.43% |
| Dec 31, 2020 | 223 | -8 | -3.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HRTX News
- 2 days ago - Heron Therapeutics, Inc. (HRTX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress - GlobeNewsWire
- 8 days ago - Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors - GlobeNewsWire
- 16 days ago - Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - GlobeNewsWire
- 2 months ago - Heron Therapeutics, Inc. Adopts Tax Benefits Preservation Plan to Protect NOL Assets and Shareholder Value - PRNewsWire
- 3 months ago - Heron Therapeutics, Inc. (HRTX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress - PRNewsWire
- 3 months ago - Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile - PRNewsWire